At a glance
ClinicalIndex Comparison RecordN/ACompleted· 78 enrolled
Drug / intervention
Gaming in a virtual environmentbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
LEveraging A viRtual eNvironment (LEARN) to Enhance Prevention of HIV-related Comorbidities in At-risk Minority MSM
In Brief
A clinical study evaluating Gaming in a virtual environment for Cardiovascular Diseases. Completed, enrolled 78 participants across 1 site.
Detailed Summary
The investigator is testing a virtual environment to address prevention of HIV-related comorbidities.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCardiovascular Diseases
CountriesUnited States
CollaboratorsNational Heart, Lung, and Blood Institute (NHLBI)
Timeline
N/ACompletedFinished
2023202420252026
First PostedFeb 2022
Enrollment StartMay 2023
Primary CompletionMar 2025
TodayJul 2026
First PostedFeb 16, 2022
Enrollment StartMay 10, 2023
Primary CompletionMar 31, 2025
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 4.4 years ago
Interventions
Gaming in a virtual environmentbehavioral
To address the primary outcomes of feasibility and acceptability of the VE, we will capture process data using a computer-based virtual environment and self-report measures using an online survey.